Brian J. Malm, MD, FACC, FASE
Cards
About
Research
Publications
2023
Opioid prescription and risk of atrial fibrillation in younger veterans
Chui P, Khokhar A, Gordon K, Dziura J, Burg M, Brandt C, Haskell S, Malm B, Bastian L, Gandhi P. Opioid prescription and risk of atrial fibrillation in younger veterans. American Heart Journal 2023, 268: 61-67. PMID: 37949420, DOI: 10.1016/j.ahj.2023.11.001.Peer-Reviewed Original ResearchTime-updated Cox regressionIncident atrial fibrillationAtrial fibrillationOpioid exposureVeterans Health AdministrationOpioid typeCox regressionOpioid prescriptionsICD-9-CM diagnostic codesIncidence of AFDevelopment of AFPrescription opioid exposureModifiable risk factorsPrimary care visitsPrescribed opioidsCare visitsOpioid useRisk factorsDiagnostic codesTime-dependent variablesOpioidsHealth AdministrationYounger veteransBaseline periodStudy samplePragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale
Joseph J, Pajewski N, Dolor R, Sellers M, Perdue L, Peeples S, Henrie A, Woolard N, Jones W, Benziger C, Orkaby A, Mixon A, VanWormer J, Shapiro M, Kistler C, Polonsky T, Chatterjee R, Chamberlain A, Forman D, Knowlton K, Gill T, Newby L, Hammill B, Cicek M, Williams N, Decker J, Ou J, Rubinstein J, Choudhary G, Gazmuri R, Schmader K, Roumie C, Vaughan C, Effron M, Cooper‐DeHoff R, Supiano M, Shah R, Whittle J, Hernandez A, Ambrosius W, Williamson J, Alexander K, Group P. Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale. Journal Of The American Geriatrics Society 2023, 71: 1701-1713. PMID: 37082807, PMCID: PMC10258159, DOI: 10.1111/jgs.18312.Peer-Reviewed Original ResearchConceptsOlder adultsHigh-intensity statin therapyRandomized pragmatic clinical trialCognitive testingBenefits of lipidInitiation of statinsBenefits of statinsNational Death Index searchEffect of statinsPragmatic clinical trialsCommunity-dwelling adultsMild cognitive impairmentLow participant burdenBaseline cognitive testingElectronic health recordsCardiovascular deathCardiovascular eventsCoronary revascularizationLipid panelStatin therapyStatin useUnstable anginaHeart failurePrimary outcomeMyocardial infarction- Philip W. Chui, Arshjot Khokhar, Kirsha S. Gordon, James Dziura, Matthew M. Burg, Cynthia Brandt, Sally G. Haskell, Brian Malm, Lori A. Bastian, Parul U. Gandhi. Opioid Prescription and Risk of Atrial Fibrillation in Younger Veterans: Opioid Use and Risk of Atrial Fibrillation. American Heart Journal, 2023.Peer-Reviewed Original Research
2022
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM, PROMINENT Investigators. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. N Engl J Med 2022, 387: 1923-1934. PMID: 36342113, DOI: 10.1056/NEJMoa2210645.Peer-Reviewed Original Research
2021
Myopericarditis with Significant Left Ventricular Dysfunction Following COVID-19 Vaccination: A Case Report
Bartlett VL, Thomas A, Hur DJ, Malm B. Myopericarditis with Significant Left Ventricular Dysfunction Following COVID-19 Vaccination: A Case Report. American Journal Of Case Reports 2021, 22: e934066-1-e934066-6. PMID: 34795198, PMCID: PMC8611472, DOI: 10.12659/ajcr.934066.Peer-Reviewed Case Reports and Technical NotesConceptsSignificant left ventricular dysfunctionLeft ventricular dysfunctionCOVID-19 vaccinationVentricular dysfunctionCOVID-19 vaccineCase reportNon-steroidal anti-inflammatory treatmentBNT162b2 COVID-19 vaccineAdverse effectsGreater cardiac dysfunctionAnti-inflammatory treatmentRare adverse effectMiddle-aged patientsSafety of vaccinesMiddle-aged menEmergency use authorizationMyopericarditis casesAdverse eventsVentricular functionCardiac dysfunctionSecond doseVaccinationMyopericarditisDysfunctionVaccineEffect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
Vardeny O, Kim K, Udell JA, Joseph J, Desai AS, Farkouh ME, Hegde SM, Hernandez AF, McGeer A, Talbot HK, Anand I, Bhatt DL, Cannon CP, DeMets D, Gaziano JM, Goodman SG, Nichol K, Tattersall MC, Temte JL, Wittes J, Yancy C, Claggett B, Chen Y, Mao L, Havighurst TC, Cooper LS, Solomon SD, INVESTED Committees and Investigators.. Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial. JAMA 2020.Peer-Reviewed Original Research
2019
Reply to letter to the editor regarding “prevalence and variability in reporting of clinically actionable incidental findings on attenuation-correction CT scans in a veteran population”
Malm BJ, He BJ, Carino M, Sadeghi MM. Reply to letter to the editor regarding “prevalence and variability in reporting of clinically actionable incidental findings on attenuation-correction CT scans in a veteran population”. Journal Of Nuclear Cardiology 2019, 27: 1054. PMID: 30825113, DOI: 10.1007/s12350-019-01667-2.Peer-Reviewed Original Research
2018
Contemporary approach to stroke prevention in atrial fibrillation: Risks, benefits, and new options
Stock J, Malm BJ. Contemporary approach to stroke prevention in atrial fibrillation: Risks, benefits, and new options. Trends In Cardiovascular Medicine 2018, 28: 469-480. PMID: 29739702, DOI: 10.1016/j.tcm.2018.03.004.Peer-Reviewed Original ResearchConceptsAtrial fibrillationStroke riskRisk factorsStroke risk factorsDirect oral anticoagulantsStrong risk factorStandard of careOral anticoagulantsMost patientsSelect patientsThromboembolic complicationsCoronary diseaseHeart failureAppropriate therapyCommon diagnosisRisk stratificationFibrillationPatientsMechanical interventionRiskTherapyNew optionsAccurate assessmentAnticoagulationHypertensionPrevalence and variability in reporting of clinically actionable incidental findings on attenuation-correction CT scans in a veteran population
He BJ, Malm BJ, Carino M, Sadeghi MM. Prevalence and variability in reporting of clinically actionable incidental findings on attenuation-correction CT scans in a veteran population. Journal Of Nuclear Cardiology 2018, 26: 1688-1693. PMID: 29492838, DOI: 10.1007/s12350-018-1232-9.Peer-Reviewed Original ResearchConceptsIncidental noncardiac findingsMyocardial perfusion imagingNoncardiac findingsPulmonary nodulesIncidental findingActionable incidental findingsVeteran populationOverall interobserver agreementAttenuation correction CTSpecific guidelinesHiatal herniaExtracardiac massPleural plaquesAortic aneurysmPhysician specialtyPerfusion imagingCommon occurringCardiologistsInterobserver agreementInterreader agreementAttenuation artifactsRadiologistsPrevalenceNodulesVeterans
2017
Derivation of a Clinical Model to Predict Unchanged Inpatient Echocardiograms
Gunderson CG, Gromisch ES, Chang JJ, Malm BJ. Derivation of a Clinical Model to Predict Unchanged Inpatient Echocardiograms. Journal Of Hospital Medicine 2017, 13: 164-169. PMID: 29073315, DOI: 10.12788/jhm.2866.Peer-Reviewed Original ResearchConceptsChronic kidney diseaseAcute myocardial infarctionCAVE scoreClinical prediction modelKidney diseaseMyocardial infarctionSingle-center retrospective cohort studyRetrospective cohort studyGood discriminationInpatient echocardiogramSubset of studiesCohort studyIndependent predictorsValvular diseaseECG changesElectrocardiogram changesC-statisticCardiothoracic surgeryRepeat studyFull cohortClinical modelDiseaseTTEΒ coefficientsInfarction
Academic Achievements and Community Involvement
Clinical Care
Overview
Brian Malm, MD, is a specialist in cardiovascular medicine, focusing on abnormalities in the heart’s valves, chambers, and walls. He performs diagnostic and surgical procedures, including cardiac catheterization, transthoracic echocardiography, and transesophageal echocardiography.
Dr. Malm’s research interests include cardiovascular disease prevention, stroke prevention in atrial fibrillation, and aortic valve and aneurysm abnormalities.
Dr. Malm has received numerous awards, including the VISN 1 Clinical Service Line Award, the Young Investigator Travel Award from the American Heart Association, the Bacelli Award for Most Outstanding Research, and the David K. Miller Prize in Medicine.
Dr. Malm is an associate professor of medicine at Yale University School of Medicine.
Clinical Specialties
Cardiac Imaging; Cardiovascular Medicine
Board Certifications
Cardiovascular Disease
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2018
- Original Certification Date
- 2008
Adult Comprehensive Echocardiography
- Certification Organization
- The National Board of Echocardiography
- Original Certification Date
- 2008
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2015
- Original Certification Date
- 2005